Clinical trial
Safety and Efficacy of Neuroform3TM for Intracranial Aneurysm Treatment
NCT00928265 · Stryker Neurovascular, Industry · Completed
Key facts
| NCT number | NCT00928265 |
|---|---|
| Title | Safety and Efficacy of Neuroform3TM for Intracranial Aneurysm Treatment |
| Official title | Safety and Efficacy of Neuroform3TM for Intracranial Aneurysm Treatment |
| Acronym | SENAT |
| Lead sponsor | Stryker Neurovascular, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Intracranial Aneurysm |
| Intervention type | Device |
| Interventions | Endovascular treatment of intracranial aneurysm. |
| Enrollment | 116 |
| Start date | Jul 1, 2008 |
| Primary completion | Sep 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jun 25, 2009 |
| Last update posted | Jun 4, 2013 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: